C10AB05 - Fenofibrate |
Propably not porphyrinogenic |
PNP |
Rationale
Substrate of CYP 3A4. No data pointing to CYP-inducing properties.
Chemical description
(To be edited, initial data ST OCT 04) Prodrug to the lipid lowering agent phenofibrate acid. Dose 200 mg/d. Metabolized by CYP 3A4. No indications of CYP-induction.
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
© NAPOS 2024